CAS: 57773-63-4
MF: C64H82N18O13
MW: 1311.45
1AppearanceWhite or slightly yellowish powder White powder
2SolubilitySoluble in water or 1% acetic acid at a concentration of 1mg/ml to give a clear, colorless solutionConforms
3Identity by HPLCThe retention is same with the reference substanceConforms
4Specific Optical Rotation-65.0- -75.0° (c=0.5, 95%HAc)-71.3°
5Amino Acid Composition± 10% of theoreticalConforms
6Peptide Purity (By HPLC)≥ 98.0% by area integration98.8%
7Related Substance (By HPLC)Total Impurities(%) ≤ 2.0% Largest Single Impurity (%) ≤ 1.0%1.2% 0.7%
8Acetate Content≤ 15.0%13.8%
9Water Content (Karl Fischer)≤ 5.0%1.5%
Usage promoting ovulation
Product Name Triptorelin Acetate
Sequence Glp-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2
Cas No. 57773-63-4
Molecular Formula C64H82N18O13
Molecular Weight 1311.46
Purity (HPLC) 98.0% min.
Appearance White powder
Single Impurity (HPLC) 1.0%max
Amino Acid Composition ±10% of theoretical
Peptide Content (N%) ≥80.0%
Water Content(Karl Fischer) ≤6.0%
Acetate Content (HPIC) ≤15.0%
MS(ESI) Consistent
Mass Balance 95.0~105.0%
Specific Rotation (20/D) -65.0~-75.0°(c=0.5 1%HAc)
Product Name | Specification |
MGF | 2mg/vial |
PEG MGF | 2mg/vial |
CJC-1295 with DAC | 2mg/vial |
CJC-1295 without DAC | 2mg/vial |
PT-141 | 10mg/vial |
MT-1 | 10mg/vial |
MT-2 | 10mg/vial |
GHRP-2 | 5mg/vial |
GHRP-2 | 10mg/vial |
GHRP-6 | 5mg/vial |
GHRP-6 | 10mg/vial |
Ipamorelin | 2mg/vial |
Hexarelin | 2mg/vial |
Sermorelin | 2mg/vial |
Oxytocin | 2mg/vial |
TB500 | 2mg/vial |
Pentadecapeptide BPC 157 | 2mg/vial |
Fragment 176-191 | 2mg/vial |
Triptorelin | 2mg/vial |
Tesamorelin | 2mg/vial |
Gonadorelin | 2mg/vial |
Gonadorelin | 10mg/vial |
DSIP | 2mg/vial |
Selank | 5mg/vial |
Follistatin 344 | 1mg/vial |
Follistatin 315 | 1mg/vial |
Epitalon | 10mg/vial |
ACE 031 | 1mg/vial |
Adipotide | 2mg/vial |
AOD-9604 | 2mg/vial |
GDF-8 | 1mg/vial |
Deslorelin | 20mg/vial |